SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: LarryS who wrote (10391)6/10/1999 4:23:00 AM
From: Chisy  Read Replies (1) | Respond to of 17367
 
Are you certain it is 10,000?



To: LarryS who wrote (10391)6/10/1999 7:55:00 PM
From: aknahow  Respond to of 17367
 
Larry, check your calendar!

American Peptide Symposium
6/25-7/1, Minneapolis, Minnesota

Jack Lin, Ph.D., XOMA, "Chemical Derivatization of the Antimicrobial Peptide,
XMP.365 for Enhancement of Oral Availability."

Kinyua Gikonyo, M.S., XOMA, "Angiogenesis Inhibition by Peptide Constructs
Derived From BPI"



September '99

ICAAC '99
26-29, San Francisco, California




To: LarryS who wrote (10391)6/11/1999 1:13:00 AM
From: aknahow  Respond to of 17367
 
Another trip to Europe for Dr. Scannon. Another Shock Forum. Gee hope BPI works, must get tiresome going to the same forum year after year with nothing considered worth putting on the XOMA web.



November '99

Vienna Shock Forum
13-16, Vienna, Austria

Pat Scannon, M.D., Ph.D., "Progress in the Clinic with rBPI-21."



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News